Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyoxidonium in hospitalized COVID-19 patients
NCT04381377Phase 3Completed
- Sponsor
- Petrovax Pharm
- Start
- Apr 2020
- Primary completion
- Mar 2021
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of azoximer bromide in coronavirus disease 2019 (COVID-19), sponsored by Petrovax Pharm. Started Apr 2020; status: completed.
02
Drugs
azoximer bromide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04381377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04381377.